Literature DB >> 15755409

Orofacial pain and sensory disorders in the elderly.

Glenn T Clark1, Hajime Minakuchi, Ana C Lotaif.   

Abstract

Many orofacial pain conditions occur in the elderly. Specifically,this article reviews the prevalence of general and orofacial-related pain in the elderly. The authors also describe and discuss the likely disorders and diseases that produce facial pain and burning pain in the mouth. They do not cover jaw joint pain, oral sores, or ulceration-induced pain, as these conditions are better discussed in the context of arthritis and oral pathologies of the mouth. The authors discuss oral motor disorders, myogenous pain, vascular pain, headaches, trigeminal neuralgia, trigeminal neuropathic dis-ease, postherpetic neuralgia, burning mouth syndrome, and occlusal dysesthesia.

Entities:  

Mesh:

Year:  2005        PMID: 15755409     DOI: 10.1016/j.cden.2004.10.011

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  3 in total

Review 1.  Phantom bite syndrome: Revelation from clinically focused review.

Authors:  Trang Thi Huyen Tu; Motoko Watanabe; Gayatri Krishnakumar Nayanar; Yojiro Umezaki; Haruhiko Motomura; Yusuke Sato; Akira Toyofuku
Journal:  World J Psychiatry       Date:  2021-11-19

2.  FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study.

Authors:  Priscilla de Albuquerque Ribeiro Gondinho; Paulo Goberlânio de Barros Silva; Mário Roberto Pontes Lisboa; Bruno Almeida Costa; Duílio Reis da Rocha Filho; Markus Andret Cavalcante Gifoni; Marcos Venicio Alves Lima; Roberto César Pereira Lima Junior; Mariana Lima Vale
Journal:  Int J Clin Oncol       Date:  2020-08-06       Impact factor: 3.402

3.  Occlusal dysesthesia-A clinical guideline.

Authors:  Bruno Imhoff; M Oliver Ahlers; Alfons Hugger; Matthias Lange; Marc Schmitter; Peter Ottl; Anne Wolowski; Jens Christoph Türp
Journal:  J Oral Rehabil       Date:  2020-03-18       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.